Senior insider sale
EVP and Chief Legal Officer at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$5.84M
12.77K shares
BILLER JONATHAN plans to sell 12.77K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $5.84M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2026 | Restricted Stock Vesting Compensation | 3.64K | — |
2/24/2026 | Restricted Stock Vesting Compensation | 314.00 | — |
2/17/2026 | Restricted Stock Vesting Compensation | 414.00 | — |
2/13/2026 | Restricted Stock Vesting Compensation | 825.00 | — |
| Total | 5.19K | ||
Completed
Units to sell
945.00
Market value
$459.6K
Units to sell
1.24K
Market value
$589.3K
Units to sell
2.48K
Market value
$1.21M
Units to sell
988.00
Market value
$493.0K
Units to sell
1.93K
Market value
$886.3K
Planned — Approximate Date
Units to sell
5.19K
Market value
$2.20M
Units
12.77K
Value
$5.84M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/25/2026 | 945.00 | $459.6K | — | Completed |
2/18/2026 | 1.24K | $589.3K | — | Completed |
2/17/2026 | 2.48K | $1.21M | — | Completed |
2/13/2026 | 988.00 | $493.0K | — | Completed |
2/11/2026 | 1.93K | $886.3K | — | Completed |
| Planned — Approximate Date | ||||
5/6/2026 | 5.19K | $2.20M | NASDAQ | Planned |
| Total | 12.77K | $5.84M | ||